The students responded in traditional Meharry form—they volunteered.
Serving at the city’s testing sites, taking patient information, bagging the samples, doing the paperwork, directing traffic—wherever they were needed, Meharry students were there.
From late March after the pandemic began, and for the next year, the three sites—mostly tents open to the elements—operated through intense summer heat and bone-chilling cold sometimes conducting thousands of tests a day. Meharrians also operated testing sites in the parking lots of area churches on any given Saturday. Before the pandemic began to ease in March 2021, the three sites operated by Meharry physicians, dentists, students, volunteers, members of the National Guard and others had administered more than 300,000 PCR COVID-19 tests for Nashvillians and Middle Tennesseans.
“When this pandemic hit, a lot of people were going away from it. Meharry ran to it. We embraced it,” Anthony Thomas, who helped run operations at one testing site, told The Tennessean last August.
According to Dr. Alex Jahangir, the head of Metro Nashville’s Coronavirus Task Force, Meharry’s role in serving the city of Nashville was pivotal. “These guys from the very beginning have been at the front line of this,” Jahangir said in a Tennessean interview. “They had the power of the people and the knowledge.”
Meharry also played a major role in the COVID-19 mitigation and reopening efforts of Metro Nashville Public Schools. Meharry clinicians and other personnel worked closely with administrators in developing a plan to make schools safe for students and teachers to return.
Meharry has played a significant role in vaccinating minority communities in Nashville where vaccine hesitancy has been a problem. Hearing a pro-vaccination message from authorities and physicians in the Black community both during clinical trials and vaccine distribution has been important in overcoming that hesitancy.
Capturing the spotlight for Meharry—and Dr. Hildreth
According to Patrick Johnson, senior vice president of institutional advancement, Meharry Medical College was somewhat of a well-kept secret in Nashville before the pandemic.
Meharry doesn’t have the things that other institutions of learning have—it’s a professional school, not a traditional university; it doesn’t have athletic teams that make the headlines; it doesn’t carry the energy of undergraduates who are finding their way into life as adults. Meharry trains postgrads—physicians, dentists, biomedical researchers and, most recently, data scientists. It’s serious work that usually doesn’t make the headlines—until now.
During the course of the pandemic, Dr. Hildreth, a national leader in infectious diseases who gained prominence in HIV research, appeared frequently with Metro Nashville Mayor John Cooper during the city’s COVID-19 briefings. Meharry’s president became the city’s chief educator on the pandemic, “explaining the contours of viral pathology in a quiet, steady voice,” said The Tennessean.
Also from The Tennessean: “‘He’s sort of Nashville’s family doctor,’ Cooper said of Hildreth in an interview. ‘There’s quite a lot of science he’s been teaching us…He is completely remarkable.’”
Dr. Hildreth became a voice for research and social issues surrounding the pandemic, finding his way to national media outlets including CNN, MSNBC, Fox News, The Wall Street Journal and others, raising the profile of Meharry along the way.
Over the course of national discussions on the pandemic including race, social determinants of health and health disparities and inequities, Dr. Hildreth became a constant presence, not only on panels and news programs, but before bodies like the House Ways and Means Committee where he made the case for Congress to provide $5 billion over five years to help the four historically Black medical schools—Meharry, Morehouse School of Medicine, Howard University College of Medicine and Charles R. Drew University of Medicine and Science—take on COVID-19 in minority neighborhoods.
Dr. Hildreth’s presentation before Congress caught the attention of former New York Mayor Mike Bloomberg who directed the newly created Greenwood Initiative of the Bloomberg Foundation to provide $100 million to the Black medical schools to offset minority student debt and help increase economic and social mobility in Black communities. Meharry saw more than $34 million of the grant—the largest single donation in the College’s history.
As the summer of 2020 progressed, Dr. Hildreth was asked to serve on the FDA screening team for granting Emergency Use Authorizations for vaccine candidates. In February of this year, he was tapped by the Biden Administration’s non-federal COVID-19 Health Equity Task Force, serving with 11 other renowned national leaders.
Meharry and COVID-19 research
Meharry’s capacity for conducting research has increased during the pandemic with one researcher developing an antiviral under consideration. Associate professor of microbiology and immunology Dr. Donald Alcendor began work on a COVID-19 antiviral in April 2020 and hopes for FDA approval sometime this year.
The antiviral differs from a vaccine in that it treats patients who have already contracted COVID-19. This virus will be with us for some time, Alcendor said, and the need to fight the disease in those unfortunate enough to get it is still important. Vaccines are important to head off contracting the disease, but antivirals are important for those who get it and are fighting it off.
Meharry and the Post-COVID world—Campaign 150
“If ever there were a need for raising financial support, it’s now,” said Johnson. “We’ve seen a heightened awareness nationwide in Meharry Medical College and the health care professionals we produce. It’s important that we build on that momentum.
“Meharry is about to turn 150 years old in 2026. What do we want to be in the next 150?”
The groundwork has been laid in recent years by the creation of the Center for the Study of the Social Determinants of Health and by the focus on data science resulting in the creation of Meharry’s fourth school of study, the School of Applied Computational Sciences. As growth spurts go, Meharry is in an ambitious phase. Buildings are needed. Laboratories are essential. Researchers and personnel are crucial.
“You have to redouble efforts at a time when growth and recognition is in the air.” Johnson said. “This is Meharry’s time.”
The COVID-19 endgame?
By mid-spring of 2021, COVID-19 cases in Tennessee had been decreasing as a result of vaccinations across the state, and testing numbers were subsiding in Middle Tennessee. The Meharry campus COVID testing site was dismantled at the end of May this year. The Kmart site was converted to a drive-thru vaccination facility, and the Nissan Stadium testing site was dismantled in July. School of Dentistry Associate Dean and Assistant Professor Dr. Julie Gray, a leader in Meharry’s citywide effort, said she had mixed emotions about the closing—she knows the closing marks progress made against the pandemic through the availability of vaccines and the reduced demand for testing, but over the past year she’s worked closely with so many of the volunteers. “You get close to these people,” she said.
But the momentum for Meharry Medical College in wake of the pandemic is upward. “People know who we are like never before,” said Johnson. “They may be aware of our history now, but they also know what we’re capable of—they want to be a part of our trip ahead.”
Epilogue: Just when we thought we had won…
Someone said it was like a horror movie where, near the end, after the monster is vanquished and everyone takes a sigh of relief—the fiend opens his eyes just before the closing credits.
In the heat of July 2021, the testing and vaccination numbers were down at the last remaining city COVID-19 assessment site, the razed Kmart on Murfreesboro Road. Since the site was seeing fewer than 40 vaccinations and 30 tests a day, site lead Sheila Brogdon decided to take some well-earned vacation days, leaving on July 26th.
Something was clearly happening in the city by the time she returned a week and a half later on August 4th. The testing numbers had grown to 450 a day. By August 25th, the numbers were bumping 1,200.
Officially, this newer version of COVID-19 was named “delta.” It was proving two things: This variant was more deadly and virulent than the earlier versions of Sars-CoV-2; and, while not an absolute rule, those who were vaccinated were faring better than the masses of unvaccinated. Overwhelmingly with percentages in the high 90s, it was the unvaccinated who began to crowd emergency rooms and intensive care wards across the nation.
With the city having optimistically closed the other two COVID assessment sites, it was clear that the pandemic had simply taken its own summer break and was coming back. The staff at the Kmart site worked to reconfigure the tents and the traffic flow to accommodate the rapidly growing volume, but soon it became clear that Nashville would need to open another site elsewhere in the city. By early September, another assessment site run by Meharrians was up and running just west of the College’s campus off of Charlotte Pike.
At the October 4, 2021 opening Convocation at Meharry Medical College, Dr. Hildreth told the virtual attendees, “We all thought—we hoped—that the end of this pandemic was in sight, but SARS-CoV-2 is not only taking a bow but an encore. As a health sciences center, we not only have a front row seat, but we are actors in the play.” Board chair Dr. Nelson Adams III said the spring-summer lull in the pandemic was “as though we have experienced a moment in the eye of a storm only to find that after a brief calm the storm was fiercely back upon us again.”
The volume at the two assessment sites ebbs and flows and optimism isn’t growing. With hope that vaccine mandates and campaigns might help rein in the pandemic, the summer surge reminded public health officials and health care workers that COVID-19 has a mind of its own, that deadly variants of the disease can come and go and that the future of Sars-CoV-2 is indeed unpredictable.
Editor’s note: The new variant is called “omicron,” and the testing—and vaccination numbers—are edging upward again.